ARCHIVES

Switching to Tasigna After Gleevec Therapy Can Achieve Deeper Molecular Response

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

NCI, EORTC Offer Support For Russian Cancer Researchers

April 14, 1995

Study: Nine Years After Diagnosis 9.3% of Survivors Still Smoke

August 29, 2014

Other DCT Concepts Approved By Board

February 26, 1988

AICR Increasing Funds for Research, Education, Supports Successful Symposium

November 7, 1986

Hood’s ISB Gets $5 Million From Merck, Hires Scientists.

September 1, 2000

In Brief: NCAB Schedules Full Day Of AIDS Discussion; PBS To Show Documentary On Tobacco Issues

November 6, 1987